The contents displayed within this public group(s), such as text, graphics, and other material ("Content") are intended for educational purposes only. The Content is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your healthcare provider with any questions you may have regarding your medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in a public group(s).
When the founders of Love CBD, Phil and Dan Culbertson, saw the success of CBD oil in the USA, they saw an opportunity for launching a CBD business in the UK. This family-run business from Newmarket, Suffolk, realised that many of the CBD oils available in the UK at that time (in 2014) were of substandard quality and decided to become CBD connoisseurs and put together blends with what they considered to be the best hemp strains out there.
After two years of R&D and lots of testing and learning, Love CBD had already established itself as one of the pioneer brands in the UK for sprays and balms. Love CBD produces some of the strongest CBD sprays we’ve found in the UK market: the 1400mg CBD Spray and the 2000mg CBD spray (both in a 20ml bottle). The CBD oil is full spectrum, with high CBDa content to achieve the entourage effect. Love CBD also supplies an XL (100g) high-strength CBD Balm with 1000mg of CBD oil content and natural ingredients only: Cannabis Sativa L., coconut oil, shea butter, cacao, grape seed oil, rosemary, and natural vanilla aroma. Ideal for a good back rub before bed. Visit the Love CBD collection.
CBD and other cannabinoids attach to specific receptors in the body found within what is referred to as the endocannabinoid system. In fact, up until recently, scientists didn’t know that these cannabinoids are actually naturally produced in humans and most animals. Some researchers speculate that an endocannabinoid deficiency may be the cause of many disorders and conditions. When CBD is introduced into the body, it binds to receptor cells called CB1 and CB2 receptors.
A number of difficulties exist in evaluating published data on CBD or marijuana use for epilepsy. The extremely limited published studies were small, poorly described, and not well designed. Contributing to the difficulty of interpreting published studies, CBD products are not produced under the guidance of good manufacturing practices (GMP) and are not subject to regulations governing labeling, purity, and reliability. In other words, currently, there is no guarantee of consistency between products, or even differing lots produced by the same manufacturer. Without independent testing (e.g. USP certification) of CBD products for content and purity, as well as bioavailability testing of specific products, uncertainty surrounds the use of available CBD products in routine clinical settings.
Although CBD oils aren’t regulated by the FDA, purchasing products stateside from one of the nine states where recreational and medical cannabis use is legal will likely result in a higher-quality product than buying one made with hemp-derived CBD oil imported from abroad, says Martin Lee, director of Project CBD, a nonprofit that promotes medical research into CBD.